DRUGS AND URIC ACID

被引:91
作者
RUNDLES, RW
WYNGAARDEN, JB
HITCHING.GH
ELION, GB
机构
来源
ANNUAL REVIEW OF PHARMACOLOGY | 1969年 / 9卷
关键词
D O I
10.1146/annurev.pa.09.040169.002021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:345 / +
页数:1
相关论文
共 249 条
[1]   RELATIONSHIPS BETWEEN GLYCOGEN STORAGE DISEASE AND TOPHACEOUS GOUT [J].
ALEPA, EP ;
HOWELL, RR ;
KLINENBE.JR ;
SEEGMILL.JE .
AMERICAN JOURNAL OF MEDICINE, 1967, 42 (01) :58-&
[2]   EFFECTS OF 4-HYDROXYPYRAZOLO(3,4-D)PYRIMIDINE UPON CATABOLISM OF PURINES BY VARIOUS TISSUES OF RAT AND UPON RATE OF GROWTH OF MORRIS 5123-C HEPATOMA [J].
ALEXANDE.JA ;
WHEELER, GP ;
HILL, DD ;
MORRIS, HP .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (07) :881-&
[3]   TREATMENT OF URIC ACID UROLITHIASIS WITH ALLOPURINOL - A XANTHINE OXIDASE INHIBITOR [J].
ALEXANDER, S ;
BRENDLER, H .
JOURNAL OF UROLOGY, 1967, 97 (02) :340-+
[4]  
ALTMAN KI, 1949, ARCH BIOCHEM, V21, P158
[7]  
ALVSAKER JO, 1968, AM RHEUMATOL ASSOC A, P19
[8]   ALLOPURINOL CONTROL OF HYPERURICOSURIA - A NEW CONCEPT IN PREVENTION OF URIC ACID STONES [J].
ANDERSON, EE ;
RUNDLES, RW ;
SILBERMAN, HR ;
METZ, EN .
JOURNAL OF UROLOGY, 1967, 97 (02) :344-+
[9]  
[Anonymous], 1968, Lancet, V1, P961
[10]  
ATSMON A, 1963, URIC ACID LITHIASIS, P252